RecruitingPhase 1 / Phase 2NCT07311746
Blood
T-cell prolymphocytic leukemia
15
studies recruiting now
as of 7 Sept 2026
155
studies registered in total
as of 7 Sept 2026
2
countries with a recruiting site
as of 7 Sept 2026
31 Dec 2025
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 1 / Phase 2NCT06810778
Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
RecruitingPhase 2NCT05805605
Allo HSCT Using RIC and PTCy for Hematological Diseases
RecruitingNCT04411043
Observatory of Prolymphocytic Leukemia T
RecruitingNCT01137825
Registry of Older Patients With Cancer
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 15 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new T-cell prolymphocytic leukemia study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About T-cell prolymphocytic leukemia
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
4 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Phase 2Venetoclax (Venclexta)
Phase 2Ibrutinib (Imbruvica)
Phase 1Alemtuzumab (Campath mabcampath)
Phase 1Itacitinib
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).